Mission
Research in Endocrine Biochemistry and Molecular Biophysics to develop and understand the causes of diseases and potential therapies for cure.
Public Charity
HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE INC
Based in Buffalo, NY, HAUPTMAN-WOODWARD MEDICAL RESEARCH INSTITUTE INC operates as a Public Charity. The organization reported $3.9M in revenue, $4.4M in expenses, $582K in total assets for fiscal year 2025. Imperigo tracks 23 reported grant relationships connected to this organization totaling approximately $1.3M.
EIN: 160807558
Buffalo, NY
Birth Defects & Genetic Diseases Research
NTEE: H20
Latest filing: 2025
Total Revenue$3.9M
Total Expenses$4.4M
Total Assets$582K
Grant Records23
Funding Total$1.3M
Filing Years2021–2025
Where $100 goes at Hauptman-Woodward Medical Research Institute Inc
How Hauptman-Woodward Medical Research Institute Inc divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.
$85
Programs
the work itself
$15
Management
running the organization
$0
Fundraising
none reported
No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.
Inside the $85 for programs
$65
IMCA-CAT provided an outstanding support environment for macro-molecular crystallography by developing and operating an efficient, reliable , high-throughput facility at which both confidential and proprietary equipment can be…
$15
Other Program Services include various research work undertaken in endocrine biochemistry and molecular biophysics to develop and understand the cause of disease and potential therapies for the cure
$3
The National HTX Center aims to implement a modern internet interface for users of the High-Throughput Crystallization Screening Center to interact with the images of their crystallization screening…
Plus 1 more program. Cost per person served and the full program breakdown are on the full profile.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Sample Grants Received
CHARITABLE SUPPORT. ANY RESTRICTIONS HAVE BEEN COMMUNICATED TO THE GRANTEE.
$33,087
For grant recipient's exempt purposes
$25,000
For grant recipient's exempt purposes
$38,500
$10,000
CHARITABLE SUPPORT. ANY RESTRICTIONS HAVE BEEN COMMUNICATED TO THE GRANTEE.
$9,380
Showing up to 5 of 23 total records — full history available with membership.
Officers & Directors
Chief Financial Officer
Anne Kent
Interim CEO
Christopher Greene
Chief Scientific Officer (Until 1/2/25)
Edward Snell
VP (until 3/31/25)
Lisa Keefe
Board Member
Michele Heffernan
Board Member/Chairperson of the Board
Sam Russo
Officer compensation and complete director data available with membership.
Top Grant Purposes
Financial Trends
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $3.9M | $4.4M | $582K |
| 2024 | $11.0M | $10.5M | $27.6M |
| 2023 | $8.7M | $9.4M | $26.9M |
| 2022 | $6.9M | $7.2M | $23.4M |
| 2021 | $9.4M | $6.9M | $26.1M |
Between 2021 and 2025, reported annual revenue declined from $9.4M to $3.9M (-58%), with total assets most recently reported at $582K.
Interactive year-over-year charts and full filing details available with membership.